Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» gene therapy
gene therapy
Replay Launches Eudora to Target Genetic Retinal Diseases
BioSpace
Tue, 11/1/22 - 12:04 pm
Replay
Eudora
gene therapy
retinal diseases
An unusual alliance opens a gene and cell therapy hub outside Boston
BioPharma Dive
Thu, 10/27/22 - 08:29 pm
Boston
cell therapy
gene therapy
Landmark Bio
Astellas Pays $50M for Access to Taysha's Rett, GAN Programs
BioSpace
Wed, 10/26/22 - 10:29 am
Taysha Gene Therapies
Astellas
gene therapy
Rett Syndrome
GAN
Novartis sales of Zolgensma gene therapy slow as market shifts
BioPharma Dive
Tue, 10/25/22 - 11:02 pm
Novartis
gene therapy
spinal muscular atrophy
SMA
Zolgensma
Astellas takes stake in gene therapy developer Taysha
BioPharma Dive
Mon, 10/24/22 - 11:12 pm
Astellas
Taysha Gene Therapies
gene therapy
Gene therapy is saving lives, but key challenges to realize its full potential
MedCity News
Thu, 10/20/22 - 10:30 am
gene therapy
Novartis
Zolgensma
Roctavian
Zynteglo
Skysona
‘We have to find a way’: FDA seeks solutions to aid bespoke gene therapy
BioPharma Dive
Fri, 10/14/22 - 10:06 am
FDA
gene therapy
BioMarin gets FDA decision date for hemophilia gene therapy, but questions on review remain
BioPharma Dive
Thu, 10/13/22 - 11:52 pm
Biomarin
FDA
hemophilia A
gene therapy
Roctavian
Pfizer pulls trigger on Voyager gene therapy capsid deal, clearing it to fire TRACER at CNS disease
Fierce Biotech
Tue, 10/4/22 - 10:48 am
Pfizer
Voyager Therapeutics
capsids
gene therapy
After $100M deal, J&J links gene therapy to improved vision in early-phase trial
Fierce Biotech
Mon, 10/3/22 - 10:11 am
JNJ
gene therapy
clinical trials
retinal disease
MeiraGTx
X-linked retinitis pigmentosa
New pediatric data shoot Rocket's gene therapy toward phase 2, leaving behind FDA concerns
Fierce Biotech
Sun, 10/2/22 - 08:04 pm
Rocket Pharmaceuticals
gene therapy
clinical trials
RP-A501
Solid Bio hopes to fortify itself after fusing with AavantiBio, but not before axing its lead asset
Fierce Biotech
Fri, 09/30/22 - 10:58 am
Solid Biosciences
M&A
gene therapy
AavantiBio
Sarepta asks FDA to approve first gene therapy for Duchenne muscular dystrophy
BioPharma Dive
Thu, 09/29/22 - 07:38 pm
Sarepta Therapeutics
Duchenne Muscular Dystrophy
FDA
gene therapy
SRP-9001
Months after exiting clinical hold, Pfizer readies to resume dosing in phase 3 gene therapy trial
Fierce Biotech
Fri, 09/23/22 - 10:50 am
Pfizer
clinical trials
hemophilia A
gene therapy
FDA
giroctocogene fitelparvovec
Rejuvinate Bio CEO highlights ambitious approach of using gene therapy to reverse aging
MedCity News
Thu, 09/22/22 - 10:12 am
gene therapy
Rejuvenate Bio
aging-related diseases
Rocket inks Renovacor buyout to propel its heart disease gene therapy ambitions
Fierce Biotech
Tue, 09/20/22 - 10:37 am
Rocket Pharmaceuticals
M&A
gene therapy
Renovacor
heart disease
Bluebird wins FDA approval of gene therapy for rare brain disorder
BioPharma Dive
Sun, 09/18/22 - 10:23 pm
Bluebird Bio
gene therapy
cALD
Skysona
FDA
Carver Bio Plants Seed to Treat Viral Threats with CRISPR Cas13
BioSpace
Thu, 09/15/22 - 11:20 pm
Carver Bio
CRISPR
funding
infectious diseases
RNA
gene therapy
ICER Deems Hemophilia Gene Therapies Worth the $2.5M Price Tag
BioSpace
Thu, 09/15/22 - 10:14 am
hemophilia
gene therapy
ICER
Biomarin
Chugai
Roche
CSL Behring
CSL takes the wraps off a big new R&D center as it eyes vaccines, cell and gene therapies
Endpoints
Wed, 09/14/22 - 09:32 am
CSL
R&D
Germany
vaccines
gene therapy
cell therapy
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »